Dr. Emily Wu has dedicated over a decade to the study and treatment of psychiatric and neurocognitive disorders, with a particular focus on cutting-edge therapies such as Transcranial Magnetic Stimulation (TMS). She is board-certified by the American Board of Psychiatry and Neurology. Dr. Wu completed her residency in General Psychiatry at the University of Texas at Houston, where she trained at one of the nations largest psychiatric hospitals. She also holds a Ph.D. in Biomedical Science from the University of Texas at Houston. Dr. Wu has extensive experience in neuromodulation treatments, including TMS, Transcranial Direct Current Stimulation (tDCS), and Electroconvulsive Therapy (ECT), which she has applied for many years to treat mood and neurocognitive disorders. She is also deeply committed to advancing research in psychiatric disorders, particularly neurocognitive disorders. As a teaching physician at the University of Texas at Houston's General Psychiatry Residency Program, Dr. Wu is passionate about educating the next generation of psychiatrists. In addition to her clinical work, Dr. Wu has published numerous peer-reviewed articles and serves on committees for several prestigious organizations, including the American Society of Clinical Psychopharmacology, the American Academy of Addiction Psychiatry, and the Texas Society of Psychiatric Physicians; Academic Committee. Dr. Wu has been recognized with multiple national awards, including the American Association's Research Colloquium for Junior Investigators, the American Academy of Addiction Psychiatry's Ruth Fox Scholarship, and fellowships from the American Society of Clinical Psychopharmacology. She also serves as a reviewer for several scientific journals. Her research focuses on exploring mechanisms and developing novel treatments for psychiatric disorders.